跳至主要内容
临床试验/EUCTR2019-003310-14-DK
EUCTR2019-003310-14-DK进行中(未招募)1 期

aser immunotherapy with and without topical anti-PD1 in basal cell carcinomas - Laser immunotherapy and topical anti-PD1

Department of Dermatology, Bispebjerg Hospital0 个研究点目标入组 20 人开始时间: 2019年11月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients 18 years or older
  • Histologically verified BCC, irrespective of histologic subtype with diameter =7 mm at baseline.
  • Signed informed consent.
  • Female subjects of childbearing potential* must be confirmed not pregnant by a negative pregnancy test prior to study treatment and must use a safe contraceptive method.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Concomitant treatment with 5-FU or imiquimod
  • Concomitant chemotherapeutic treatment
  • Concomitant systemic immunotherapeutic treatment
  • Pregnant or lactating women
  • Allergies to anti-PD1
  • Patients with a tendency to form keloids
  • Other skin diseases or tattoos in the treatment area.

研究者

发起方
Department of Dermatology, Bispebjerg Hospital

相似试验